MTMR7: A Key Enzyme in The PI3K/Akt Pathway (G9108)

Target Name: MTMR7

NCBI ID: G9108

MTMR7

MTMR7: A Key Enzyme in The PI3K/Akt Pathway

MTMR7 (Phosphatidylinositol-3-phosphate phosphatase) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key enzyme in the intracellular signaling pathway known as the PI3K/Akt pathway, which is involved in a wide range of physiological processes, including cell survival, growth, and inflammation.

MTMR7 is a type of enzyme that is known as a phosphatase, which means that it removes phosphates from other proteins. In the case of MTMR7, it removes phosphates from the protein phosphatidylinositol-3-phosphate (PIP), which is a key component of the PI3K/Akt pathway.

The PI3K/Akt pathway is a complex signaling pathway that is involved in many different processes in the body, including the regulation of cell growth, differentiation, and survival. It is activated by the presence of an enzyme called IP3 (inositol trisphosphate), which causes the phosphate ions to become retained inositol channels in the cell membrane. When IP3 binds to its receptor on the surface of the IP3 receptor, it causes the receptor to become activated, leading to the release of other molecules that activate the pathway.

MTMR7 is a key enzyme in the PI3K/Akt pathway because it is involved in the breakdown of IP3, which is necessary for the pathway to be activated. When IP3 binds to its receptor, it causes the receptor to become activated, leading to the release of other molecules that activate the pathway. MTMR7 is the enzyme that removes the phosphates from the protein phosphatidylinositol-3-phosphate, which allows the IP3 receptor to remain activated and continue to regulate the PI3K/Akt pathway.

MTMR7 is also involved in the regulation of cell death and in the development of certain diseases. For example, MTMR7 has been shown to be involved in the regulation of cell death in cancer cells. It has also been shown to be involved in the development of certain neurological diseases, such as Alzheimer's disease and Parkinson's disease.

As a potential drug target, MTMR7 is an attractive target for researchers because it is involved in the regulation of many different physiological processes in the body, and it is also involved in the development of certain diseases. Researchers are currently working to develop new drugs that can inhibit the activity of MTMR7 and treat a wide range of diseases.

In addition to its potential as a drug target, MTMR7 is also an attractive biomarker for certain diseases. For example, MTMR7 has been shown to be decreased in the brains of people with Alzheimer's disease, which suggests that it may be an important biomarker for this disease. Similarly, MTMR7 has been shown to be decreased in the brains of people with Parkinson's disease, which suggests that it may be an important biomarker for this disease.

Overall, MTMR7 is a protein that is involved in the regulation of many different physiological processes in the body. It is a key enzyme in the PI3K/Akt pathway and is also involved in the regulation of cell death and in the development of certain diseases. As a potential drug target and biomarker, MTMR7 is an attractive target for researchers because it is involved in the regulation of many different physiological processes in the body and is also involved in the development of certain diseases.

Protein Name: Myotubularin Related Protein 7

Functions: Phosphatase that specifically dephosphorylates phosphatidylinositol 3-phosphate (PtdIns(3)P) and inositol 1,3-bisphosphate (Ins(1,3)P2)

The "MTMR7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTMR7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets